10,401
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Pomalidomide, dexamethasone, and daratumumab immediately after lenalidomide-based treatment in patients with multiple myeloma: updated efficacy, safety, and health-related quality of life results from the phase 2 MM-014 trial

, ORCID Icon, , , , , , , , , , , , , , , , , & show all
Pages 1407-1417 | Received 21 Sep 2021, Accepted 09 Jan 2022, Published online: 08 Feb 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.